These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31225756)

  • 1. The Human Right to Science and the Regulation of Human Germline Engineering.
    Boggio A; Knoppers BM; Almqvist J; Romano CPR
    CRISPR J; 2019 Jun; 2():134-142. PubMed ID: 31225756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ordo-Responsibility for Germline Gene Editing.
    Ranisch R; Rudolph T; Cremer HJ; Knoepffler N
    CRISPR J; 2020 Feb; 3(1):37-43. PubMed ID: 32091257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
    Burbery R
    J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethics and Global Governance of Human Germline Genome Editing: The Problem of Techno-Scientific Colonialist Paternalism.
    Arguedas-Ramírez G
    CRISPR J; 2020 Apr; 3(2):83-88. PubMed ID: 32315224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focusing on Human Rights: a framework for CRISPR germline genome editing ethics and regulation.
    Doxzen K; Halpern J
    Perspect Biol Med; 2020; 63(1):44-53. PubMed ID: 32063585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.
    Guttinger S
    Sci Eng Ethics; 2018 Aug; 24(4):1077-1096. PubMed ID: 28653169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRISPR babies controversy: Responsibility and regulation in the spotlight.
    Meyer M
    EMBO Rep; 2020 Jul; 21(7):e50307. PubMed ID: 32468716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The trust game: CRISPR for human germline editing unsettles scientists and society.
    Braun M; Meacham D
    EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30602586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upstream Ethical Mapping of Germline Genome Editing.
    Halpern J; Paolo D
    Am J Bioeth; 2020 Aug; 20(8):1-4. PubMed ID: 32804067
    [No Abstract]   [Full Text] [Related]  

  • 14. Who Goes First? Deaf People and CRISPR Germline Editing.
    Padden C; Humphries J
    Perspect Biol Med; 2020; 63(1):54-65. PubMed ID: 32063586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Council of Europe should not reaffirm the ban on germline genome editing in humans.
    Sykora P; Caplan A
    EMBO Rep; 2017 Nov; 18(11):1871-1872. PubMed ID: 28986351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Governing Human Germline Editing Through Patent Law.
    Sherkow JS; Adashi EY; Cohen IG
    JAMA; 2021 Sep; 326(12):1149-1150. PubMed ID: 34459849
    [No Abstract]   [Full Text] [Related]  

  • 19. Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights?
    Halpern J; O'Hara SE; Doxzen KW; Witkowsky LB; Owen AL
    CRISPR J; 2019 Oct; 2(5):293-298. PubMed ID: 31599687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing: The efficient tool CRISPR-Cpf1.
    Mahfouz MM
    Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.